Assessing the effectiveness of topical peppermint cream and orally ingestible peppermint oxymel mouthwash on halitosis and vomiting of breast cancer patients during chemotherapy

Phase 3

Recruiting

• Conditions: Breast cancer patients treated with chemotherapy drugs.; Malignant neoplasm of breast

• Registration Number: IRCT20201219049763N1
• Lead Sponsor: Iranian academic center for education culture and research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 June 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 225

Inclusion Criteria

No history of nausea and vomiting for other reasons
Full consciousness
Literacy
Complete satisfaction in participating in this project
Breast cancer, ac4T4 chemotherapy regimen, taking anti-nausea and vomiting drugs Aprepitant and Dexamethasone
No history of allergies Medicinal plants
No history of respiratory diseases, asthma, diabetes and autoimmune diseases

Exclusion Criteria

Eliminate patients who use medications or treatments other than those prescribed during the study to reduce nausea and vomiting
Patients who forget to use the product and mouthwash three or more times in a row

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ausea score in questionnaires. Timepoint: At the beginning of the study, every day based on the Daily questionnaire, every 14 days based on the Rhodes questionnaire. Method of measurement: Daily questionnaire and Rhodes questionnaire.;Halitosis scores on questionnaires. Timepoint: At the beginning of the study, every day based on the Daily questionnaire, every 14 days based on the Rhodes questionnaire. Method of measurement: Daily questionnaire and Rhodes questionnaire.